Harbor Investment Advisory, LLC Ptc Therapeutics, Inc. Transaction History

Harbor Investment Advisory, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 14, 2023	BUY	$40.4 - $59.1 $7,676 - $11,229	190 Added 15.47%	1,418 $57,000
Q1 2023 Apr 21, 2023	BUY	$38.16 - $48.86 $5,647 - $7,231	148 Added 13.7%	1,228 $59,000
Q1 2021 Apr 16, 2021	BUY	$46.8 - $68.92 $7,020 - $10,338	150 Added 16.13%	1,080 $51,000
Q4 2020 Feb 04, 2021	BUY	$47.96 - $67.64 $17,793 - $25,094	371 Added 66.37%	930 $57,000
Q3 2020 Oct 23, 2020	BUY	$45.41 - $57.07 $14,077 - $17,691	310 Added 124.5%	559 $26,000
Q1 2020 May 11, 2020	BUY	$32.37 - $59.36 $8,060 - $14,780	249 New	249 $11,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Harbor Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Harbor Investment Advisory, LLC with notifications on news.